fda approvals in ovarian cancer and merkel cell carcinoma
Published 7 years ago • 207 plays • Length 7:01Download video MP4
Download video MP3
Similar videos
-
10:39
fda approvals in ovarian cancer, merkel cell carcinoma, itp, and more
-
1:42
dr. hamid on the fda approval of pembrolizumab in merkel cell carcinoma
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
-
6:44
fda approval in rare leukemias, priority reviews in msi-h cancers and mcc, and more
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
6:31
fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma
-
1:03
role of immunotherapy in merkel cell carcinoma
-
2:19
dr. arend on fda approval of frontline bevacizumab in ovarian cancer
-
0:26
retifanlimab in merkel cell carcinoma
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
1:08
novel approaches in treating merkel cell carcinoma
-
5:50
beating merkel cell carcinoma with immunotherapy
-
54:34
uncovering merkel cell polyomavirus
-
3:19
labs in action: a new immunotherapy treatment for merkel cell carcinoma
-
2:04
dr. gandhi on pembrolizumab/chemo findings in nsclc and fda approval
-
0:58
dermatologist explains jimmy buffet’s fatal skin cancer merkel cell carcinoma
-
0:57
dr. infante on avelumab's potential in ovarian cancer